Weight and BMI changes during 6-month TCZ therapy. Values are mean (SD) unless otherwise specified.
| Characteristics | Baseline, n = 207* | Δ M3 − M0 | Δ M6 − M0 | ||
|---|---|---|---|---|---|
| n = 157 | p | n = 157 | p | ||
| Weight, kg | 66.57 (16.5) | +0.65 (3.43) | 0.001 | +0.83 (3.32) | 0.001 |
| BMI, kg/m2 | 25.1 (5.8) | +0.25 (1.28) | 0.002 | +0.34 (1.26) | < 0.001 |
↵* 15 patients had missing values for weight and/or height. BMI: body mass index; TCZ: tocilizumab; Δ M3 − M0: difference between 3 months and baseline; Δ M6 − M0: difference between 6 months and baseline.